Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


John D'Arcy: Supervision in pharmacies 'has got to change'

Numark’s managing director has said the sector needs to take a “broader view” on the supervision of pharmacies, to allow pharmacists more “headroom”.

In a letter, sent to Royal Pharmaceutical Society (RPS) assembly candidates last week, contractors Mike Hewitson and Ben Merriman stated that “many community pharmacists are extremely concerned” that the Department of Health plans to “empower pharmacy technicians to supervise pharmacies”.

Speaking to C+D the day after the announcement of his upcoming retirement, John D'Arcy said supervision rules “have got to change” to allow pharmacists to complete additional clinical work.

"It doesn’t make sense to be...physically checking every single prescription you dispense,” he said on Tuesday (July 18).

“Some pharmacies can’t do any more scripts and do it safely. You look at the volume and think: something’s got to give.”

The debate over supervision has been "raging" throughout his 37-year pharmacy career, Mr D’Arcy said. “I am not for one minute suggesting we don’t have pharmacists involved in community pharmacy,” he stressed.

However, the sector needs to implement a system that allows for more “headroom, retains accountability, retains the importance of pharmacists” and “starts a process that allows us to do more of what we need to be doing”, he added.

“Sensitivities” around supervision

“I fully understand the sensitivity around...pharmacists becoming redundant...if you allow technicians to supervise," he said.

But Mr D'Arcy pointed out that “with supervision, if you don’t relax it, you become so busy that you can’t do it.”

Pharmacy teams cannot take on any more work, unless there is a “radical rethink” to the “process of adding value to prescription supply”, he added.

Although supervision cannot be ignored, the “bigger debate has to be around accountability”, Mr D’Arcy said.

"The key thing is to have a process – a quality assurance system – to say, 'I'm accountable for that prescription, and it if goes wrong, it is my name on the block'," he added.

Do you agree with John D'Arcy?

Related Content


Yeovil, Winchester & Dorchester
£50-55,000 per annum

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts